OMA1 High-Throughput Screen Reveals Protease Activation by Kinase Inhibitors
Open Access
- 21 October 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 16 (11) , 2202-2211
Abstract
Mitochondrial proteases are interesting but challenging drug targets for multifactorial diseases, such as neurodegeneration and cancer. The mitochondrial inner membrane protease OMA1 is a bona fide drug target for heart failure supported by data from human linkage analysis and animal disease models, but presumably relevant for more indications. OMA1 acts at the intersection of energy metabolism and stress signaling. The protease cleaves the structural protein OPA1, which organizes the cristae, as well as the signaling peptide DELE1, which can stimulate the integrated stress response. OMA1 shows little activity under physiological conditions but hydrolyzes OPA1 in mitochondria destined for mitophagy and during apoptosis. Little is known about OMA1, its structure has not been solved, let alone its context-dependent regulation. Autocatalytic processing and the lack of OMA1 inhibitors are thereby creating the biggest roadblocks. This study introduces a scalable, cellular OMA1 protease assay suitable for high-throughput drug screening. The assay utilizes an engineered luciferase targeted to the inner membrane as artificial OMA1 substrate, whereby the reporter signal inversely correlates to OMA1 activity. Testing different screening protocols and sampling different compound collections validated the reporter and demonstrated that both OMA1 activators as well as OMA1 inhibitors can be identified with the assay. Ten kinase-targeted cancer drugs triggered OMA1 in the assays, which suggests—considering cardiotoxicity as a rather common side-effect of this class of drugs—cross-reactivity with the OMA1 pathway.Keywords
Funding Information
- National Institute on Aging (R43AG063642)
This publication has 63 references indexed in Scilit:
- Mitochondrial Fission, Fusion, and StressScience, 2012
- Engineered Luciferase Reporter from a Deep Sea Shrimp Utilizing a Novel Imidazopyrazinone SubstrateACS Chemical Biology, 2012
- Selective Oma1 Protease-mediated Proteolysis of Cox1 Subunit of Cytochrome Oxidase in Assembly MutantsJournal of Biological Chemistry, 2012
- Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell ProliferationAnnual Review of Cell and Developmental Biology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Regulation of OPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1Journal of Cell Biology, 2009
- Inducible proteolytic inactivation of OPA1 mediated by the OMA1 protease in mammalian cellsJournal of Cell Biology, 2009
- Mitochondrial OPA1, apoptosis, and heart failureCardiovascular Research, 2009
- OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1LJournal of Cell Biology, 2007
- Regulation of mitochondrial morphology through proteolytic cleavage of OPA1The EMBO Journal, 2006